    |
Latest Biotech News
biotech - Yahoo! Search ResultsPress Release
All signs point to emerging biotech company Rainbow Coral Corp. (OTCBB:RBCC) finding its feet in biotechnology at exactly the right time: The biotech industry is off to a great start in the early stages of 2012.
Edison Expands European Biotech Presence with Initiation of Research Coverage on Transgene
LONDON--(BUSINESSWIRE)-- Edison Investment Research, a UK-based independent equity research firm, announces the initiation of research coverage on Transgene (NYSE Euronext Paris: TNG), a French immunotherapy ...
Biotech firm’s profits and growth prospects a breath of fresh air
A BIOTECH firm backed by Sir Chris Evans yesterday told the market that trading was in line with expectations.
EU agency issues guideline on biosimilar MS drugs
LONDON (Reuters) - European regulators took another step towards opening the market for copies of biotech drugs on Friday by releasing a draft guideline on how companies should test biosimilar medicines containing interferon beta, used to treat multiple sclerosis.
Cellexus fundraising to back global expansion
Cellexus, a growing biotech company specialising in high quality, next-generation, disposable, single-use bioreactor systems and consumables has moved from Huntingdon to Granta Park at the heart of the Cambridge BioMedTech cluster in the UK. Read more...
e-Therapeutics Outlines Goals for 2012 and Announces Presentation at Biotech Showcase Conference
OXFORD & NEWCASTLE, England--(BUSINESSWIRE)-- Drug discovery and development company e-Therapeutics plc (AIM: ETX) today provides an update on its goals and expectations for 2012. Four drugs to enter clinical ...
Bactest wins £900k investment
Cambridge-based biotech company BACTEST Ltd has closed a £900k funding round led by the Low Carbon Innovation Fund (LCIF), managed by Turquoise International, which invested £300k in BACTEST. Read more...
Bristol-Myers Squibb targets hepatitis C with $2.5bn deal to buy Inhibitex
American pharmaceutical giant Bristol-Myers Squibb is set to buy US biotech company Inhibitex in a $2.5bn (£1.6bn) deal, bolstering its portfolio of drugs targeting the burgeoning hepatitis C market.
Mans gets life for millionaire's murder in fraud scheme
(Reuters) - A judge in Southern California on Friday sentenced a former financial advisor to life in prison for strangling a wealthy biotech executive and attempting to steal $9 million from one of his investment accounts.
Roche makes $5.7bn bid for Illumina
Roche has launched a $5.7bn (£3.7bn) hostile offer for American gene sequencing business, Illumina, as the Swiss drug maker moves to strengthen its presence in diagnostics and personalised medicine.
    |
|